An open trial of app-assisted acceptance and commitment therapy (iACT) for eating disorders in type 1 diabetes.

ABSTRACT:

Background

Eating disorders (EDs) among individuals with type 1 diabetes (T1D) increase the risk of early and severe diabetes-related medical complications and premature death. Conventional eating disorder (ED) treatments have been largely ineffective for T1D patients, indicating the need to tailor treatments to this patient population and the unique conditions under which ED symptoms emerge (in the context of a chronic illness with unrelenting demands to control blood glucose, diet and exercise). The current study was a pilot open trial of iACT, a novel intervention for EDs in T1D grounded in Acceptance and Commitment Therapy (ACT). iACT was based on the premise that ED symptoms emerge as individuals attempt to cope with T1D and related emotional distress. iACT taught acceptance a

SUBMITTER: Merwin RM 

PROVIDER: S-EPMC7789378 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature